You are here

Article Text

Article menu
Download PDFPDF
Letter
International survey on the diagnosis and management of gout
  1. M Doherty1,
  2. T Bardin2,
  3. E Pascual3
  1. 1
    Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham, UK
  2. 2
    Fédération de Rhumatologie Hôpital Lariboisière, Paris, France
  3. 3
    Hospital General Universitario de Alicante, Alicante, Spain
  1. Professor M Doherty, Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; michael.doherty{at}nottingham.ac.uk

https://doi.org/10.1136/ard.2007.071530

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The pathogenesis of urate crystal deposition is reasonably well understood, and with appropriate urate-lowering therapy (ULT) and lifestyle advice, the objective of management is cure. Nonetheless, many patients with gout continue to experience frequent and recurrent episodes of gout and progression of their disease. This is because the condition is often misdiagnosed, or diagnosed late, and treatment is frequently suboptimal.1 2 These concerns led to the development of evidence-based recommendations relating to the diagnosis and management of gout by a task force from the European League Against Rheumatism (EULAR). The EULAR recommendations were developed using a combination of research-based evidence and expert consensus, and provide a valuable resource for physicians.1 2

    The current diagnosis and management …

    View Full Text

    Footnotes

    • Funding: The study was financed by Ipsen, France, for which the authors are grateful.